18 June 2013
Keywords: clexane, nexavar, rcc, approved, japan, french, drug
Article | 04 February 2008
French drug major Sanofi-Aventis says that its anticoagulant Clexane (enoxaparin sodium injection) has been approved for marketing in Japan
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 February 2008
17 June 2013
© 2013 thepharmaletter.com